STOCK TITAN

BCHTD Financials

BCHTD
Source SEC Filings (10-K/10-Q) Updated Mar 31, 2026 Currency USD FYE December

This page shows BCHTD (BCHTD) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 16 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI BCHTD FY2025

Cost cutting narrowed losses, but short-term liabilities still fund a business running on a nearly flat $17.6M sales base.

Across FY2023-FY2025, sales were roughly unchanged while operating cash flow swung from $19.2M inflow to -$700K. With cash down to $2.2M against current liabilities of $10.7M, the company appears to have unwound a temporary cash windfall rather than built a repeatable cash engine; FY2025's improvement is therefore more about narrower losses than a rebuilt liquidity buffer.

FY2025's smaller loss came mainly from a cost reset, not renewed growth: gross margin improved to 42.0% and selling costs fell to $8.6M. Because revenue barely moved versus FY2024, the narrower operating loss points to expense discipline and lighter overhead, not a different demand level. Research spending of $1.8M also means part of the remaining loss now comes from chosen investment, not just legacy overhead.

The balance sheet still looks liquidity-constrained: cash of $2.2M covers only part of current liabilities of $10.7M. At the same time, interest expense fell to just $14K and equity turned negative again, so the operating strain is less about expensive borrowing and more about near-term obligations outweighing readily available resources. That makes collections, inventory turns, and payment timing especially important to day-to-day stability.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Profitability Growth Leverage Liquidity Cash Flow Returns 32 / 100
Financial Profile 32/100

Based on FY2025 annual data, averaged across the last 3 years for performance metrics (most-recent year weighted highest). How this score is calculated →

Health score ≠ stock price. This rates the quality of BCHTD's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability
0

BCHTD has an operating margin of -17.2%, meaning the company retains $-17 of operating profit per $100 of revenue. This below-average margin results in a low score of 0/100, suggesting thin profitability after operating expenses. This is up from -41.1% the prior year.

Growth
33

BCHTD's revenue grew a modest 1.3% year-over-year to $17.6M. This slow but positive growth earns a score of 33/100.

Leverage
0

BCHTD has elevated debt relative to equity (D/E of -6.39), meaning the company relies heavily on borrowed funds. This high leverage results in a low score of 0/100, reflecting increased financial risk.

Liquidity
4

BCHTD's current ratio of 0.47 is below the typical benchmark, resulting in a score of 4/100. This tight liquidity could limit financial flexibility if cash inflows slow.

Cash Flow
53

While BCHTD generated -$700K in operating cash flow, capex of $29K consumed most of it, leaving -$729K in free cash flow. This results in a low score of 53/100, reflecting heavy capital investment rather than weak cash generation.

Piotroski F-Score Neutral
4/9

BCHTD passes 4 of 9 financial strength tests. 2 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), both operating efficiency signals pass.

Earnings Quality Low Quality
0.23x

For every $1 of reported earnings, BCHTD generates $0.23 in operating cash flow (-$700K OCF vs -$3.0M net income). This low ratio suggests earnings are primarily driven by accounting accruals rather than cash generation, which may not be sustainable.

Interest Coverage At Risk
-221.6x

BCHTD earns $-221.6 in operating income for every $1 of interest expense (-$3.0M vs $14K). This narrow margin raises concern about the company's ability to service its debt if operating income declines.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$17.6M
YoY+1.3%
5Y CAGR+16.7%
10Y CAGR+3.4%

BCHTD generated $17.6M in revenue in fiscal year 2025. This represents an increase of 1.3% from the prior year.

EBITDA
-$2.7M
YoY+62.4%

BCHTD's EBITDA was -$2.7M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 62.4% from the prior year.

Net Income
-$3.0M
YoY+72.0%

BCHTD reported -$3.0M in net income in fiscal year 2025. This represents an increase of 72.0% from the prior year.

EPS (Diluted)
$-0.16
YoY+71.9%

BCHTD earned $-0.16 per diluted share (EPS) in fiscal year 2025. This represents an increase of 71.9% from the prior year.

Cash & Balance Sheet

Free Cash Flow
-$729K
YoY+85.2%

BCHTD generated -$729K in free cash flow in fiscal year 2025, representing cash available after capex. This represents an increase of 85.2% from the prior year.

Cash & Debt
$2.2M
YoY-35.0%
5Y CAGR+30.6%
10Y CAGR+7.6%

BCHTD held $2.2M in cash against $0 in long-term debt as of fiscal year 2025.

Dividends Per Share
N/A
Shares Outstanding
19M
YoY+1.1%

BCHTD had 19M shares outstanding in fiscal year 2025. This represents an increase of 1.1% from the prior year.

Margins & Returns

Gross Margin
42.0%
YoY+1.2pp
5Y CAGR+8.7pp
10Y CAGR+27.2pp

BCHTD's gross margin was 42.0% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is up 1.2 percentage points from the prior year.

Operating Margin
-17.2%
YoY+23.9pp
10Y CAGR+12.0pp

BCHTD's operating margin was -17.2% in fiscal year 2025, reflecting core business profitability. This is up 23.9 percentage points from the prior year.

Net Margin
-17.2%
YoY+44.9pp
5Y CAGR+54.2pp
10Y CAGR+95.7pp

BCHTD's net profit margin was -17.2% in fiscal year 2025, showing the share of revenue converted to profit. This is up 44.9 percentage points from the prior year.

Return on Equity
N/A

Capital Allocation

R&D Spending
$1.8M

BCHTD invested $1.8M in research and development in fiscal year 2025.

Share Buybacks
N/A
Capital Expenditures
$29K
YoY-96.4%

BCHTD invested $29K in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents a decrease of 96.4% from the prior year.

BCHTD Income Statement

Metric Q1'26 Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q2'24
Revenue $4.2M+11.9% $3.8M-48.5% $7.4M+126.2% $3.3M+1.0% $3.2M-42.1% $5.6M+6.3% $5.2M+55.8% $3.4M
Cost of Revenue $2.9M+8.9% $2.6M-21.2% $3.3M+45.7% $2.3M+15.1% $2.0M-11.7% $2.2M-38.3% $3.6M+58.3% $2.3M
Gross Profit $1.4M+18.5% $1.2M-71.1% $4.0M+316.5% $968K-21.6% $1.2M-62.8% $3.3M+108.0% $1.6M+50.4% $1.1M
R&D Expenses $551K+17.2% $470K-0.8% $473K+3.9% $455K+12.0% $407K $0 $0 $0
SG&A Expenses $2.0M+1.1% $2.0M-28.7% $2.7M+61.8% $1.7M-21.8% $2.2M-35.3% $3.4M+24.1% $2.7M-41.7% $4.6M
Operating Income -$1.1M+12.5% -$1.3M-261.9% $811K+168.4% -$1.2M+11.7% -$1.3M-1603.5% -$79K+92.9% -$1.1M+69.0% -$3.6M
Interest Expense $0-100.0% $14K $0 $0-100.0% $54-99.4% $8K+15.1% $7K+26.5% $6K
Income Tax $357-99.3% $55K+8624.5% $629+53.8% $409-97.1% $14K+200.7% $5K+101.6% -$294K-85129.8% $346
Net Income -$1.3M-126.9% -$593K-175.2% $788K+151.1% -$1.5M+8.2% -$1.7M-25.1% -$1.3M-193.5% -$458K+92.6% -$6.1M
EPS (Diluted) $-0.06 N/A $0.01+150.0% $-0.02+77.8% $-0.09 N/A $0.00+100.0% $-0.07

BCHTD Balance Sheet

Metric Q1'26 Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q2'24
Total Assets $21.4M+131.6% $9.2M-8.9% $10.1M+18.2% $8.6M-7.8% $9.3M-9.4% $10.3M-12.0% $11.7M-21.0% $14.7M
Current Assets $17.7M+254.7% $5.0M-17.0% $6.0M+31.8% $4.6M-12.1% $5.2M-14.8% $6.1M-19.6% $7.6M-33.0% $11.3M
Cash & Equivalents $14.7M+556.8% $2.2M+27.0% $1.8M+21.6% $1.5M-54.4% $3.2M-7.8% $3.5M-21.3% $4.4M-47.9% $8.4M
Inventory $594K+32.6% $448K-10.1% $498K-40.0% $831K+40.3% $592K-4.8% $622K-29.9% $886K-8.1% $965K
Accounts Receivable $2.2M+6.7% $2.1M-42.2% $3.6M+68.1% $2.2M+69.0% $1.3M-29.9% $1.8M-5.6% $1.9M+8.2% $1.8M
Goodwill N/A N/A N/A N/A N/A N/A N/A N/A
Total Liabilities $10.2M-6.6% $11.0M-2.9% $11.3M+7.2% $10.5M+8.2% $9.7M+7.3% $9.1M-6.9% $9.7M-22.2% $12.5M
Current Liabilities $10.0M-6.6% $10.7M-2.8% $11.1M+7.5% $10.3M+8.5% $9.5M+7.6% $8.8M+120.9% $4.0M-38.6% $6.5M
Long-Term Debt N/A N/A N/A N/A N/A N/A N/A N/A
Total Equity $11.2M+751.3% -$1.7M-50.2% -$1.1M+41.4% -$1.9M-356.7% -$427K-135.8% $1.2M-52.1% $2.5M-11.0% $2.8M
Retained Earnings -$77.1M-1.8% -$75.8M-0.8% -$75.2M+1.0% -$76.0M-2.1% -$74.4M-2.3% -$72.8M-1.1% -$72.0M-0.7% -$71.5M

BCHTD Cash Flow Statement

Metric Q1'26 Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q2'24
Operating Cash Flow -$2.2M-328.8% $964K+200.2% $321K+118.6% -$1.7M-580.8% -$254K+69.4% -$830K-445.7% -$152K+94.3% -$2.7M
Capital Expenditures $0-100.0% $6K-17.2% $7K+237.4% $2K-85.1% $14K-86.8% $107K-83.1% $636K+859.3% $66K
Free Cash Flow -$2.2M-330.3% $958K+205.1% $314K+118.1% -$1.7M-545.7% -$268K+71.4% -$938K-19.0% -$788K+71.3% -$2.7M
Investing Cash Flow $0+100.0% -$6K+17.2% -$7K-237.4% -$2K+85.1% -$14K+86.8% -$107K+83.1% -$636K-859.3% -$66K
Financing Cash Flow $14.7M+3156.6% -$481K $0 $0 $0 $0+100.0% -$3.3M $0
Dividends Paid N/A N/A N/A N/A N/A N/A N/A N/A
Share Buybacks N/A N/A N/A N/A N/A N/A N/A N/A

BCHTD Financial Ratios

Metric Q1'26 Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q2'24
Gross Margin 32.6%+1.8pp 30.8%-24.0pp 54.8%+25.0pp 29.8%-8.6pp 38.3%-21.3pp 59.6%+29.1pp 30.4%-1.1pp 31.6%
Operating Margin -27.1%+7.5pp -34.6%-45.6pp 11.0%+47.4pp -36.4%+5.3pp -41.7%-40.3pp -1.4%+19.7pp -21.1%+85.2pp -106.3%
Net Margin -31.7%-16.1pp -15.7%-26.4pp 10.7%+58.1pp -47.4%+4.7pp -52.1%-28.0pp -24.1%-15.4pp -8.7%+174.1pp -182.9%
Return on Equity -12.0% N/A N/A N/A N/A -112.7%-94.3pp -18.4%+201.7pp -220.1%
Return on Assets -6.3%+0.1pp -6.4%-14.2pp 7.8%+25.8pp -18.0%+0.1pp -18.1%-5.0pp -13.1%-9.2pp -3.9%+37.7pp -41.7%
Current Ratio 1.77+1.3 0.47-0.1 0.55+0.1 0.44-0.1 0.55-0.1 0.69-1.2 1.90+0.2 1.74
Debt-to-Equity 0.92+7.3 -6.39+3.5 -9.88-4.5 -5.40+17.4 -22.79-30.4 7.61+3.7 3.92-0.6 4.48
FCF Margin -52.0%-77.3pp 25.3%+21.0pp 4.3%+57.6pp -53.3%-44.9pp -8.3%+8.5pp -16.9%-1.8pp -15.0%+66.8pp -81.8%

Note: Shareholder equity is negative (-$1.7M), which causes debt-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.

Note: The current ratio is below 1.0 (0.47), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.

Frequently Asked Questions

BCHTD (BCHTD) reported $17.6M in total revenue for fiscal year 2025. This represents a 1.3% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

BCHTD (BCHTD) revenue grew by 1.3% year-over-year, from $17.4M to $17.6M in fiscal year 2025.

No, BCHTD (BCHTD) reported a net income of -$3.0M in fiscal year 2025, with a net profit margin of -17.2%.

BCHTD (BCHTD) reported diluted earnings per share of $-0.16 for fiscal year 2025. This represents a 71.9% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

BCHTD (BCHTD) had EBITDA of -$2.7M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

BCHTD (BCHTD) had a gross margin of 42.0% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

BCHTD (BCHTD) had an operating margin of -17.2% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

BCHTD (BCHTD) had a net profit margin of -17.2% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

BCHTD (BCHTD) generated -$729K in free cash flow during fiscal year 2025. This represents a 85.2% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

BCHTD (BCHTD) generated -$700K in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

BCHTD (BCHTD) had $9.2M in total assets as of fiscal year 2025, including both current and long-term assets.

BCHTD (BCHTD) invested $29K in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

BCHTD (BCHTD) invested $1.8M in research and development during fiscal year 2025.

BCHTD (BCHTD) had 19M shares outstanding as of fiscal year 2025.

BCHTD (BCHTD) had a current ratio of 0.47 as of fiscal year 2025, which is below 1.0, which may suggest potential liquidity concerns.

BCHTD (BCHTD) had a debt-to-equity ratio of -6.39 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

BCHTD (BCHTD) had a return on assets of -32.8% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

Based on fiscal year 2025 data, BCHTD (BCHTD) had $2.2M in cash against an annual operating cash burn of $700K. This gives an estimated cash runway of approximately 38 months at the current burn rate. Cash runway measures how long a company can continue operating before running out of cash, assuming no additional funding.

BCHTD (BCHTD) has negative shareholder equity of -$1.7M as of fiscal year 2025, which causes the debt-to-equity ratio to appear negative or not meaningful. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.

BCHTD (BCHTD) has a Piotroski F-Score of 4 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

BCHTD (BCHTD) has an earnings quality ratio of 0.23x, considered low quality (accrual-driven). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

BCHTD (BCHTD) has an interest coverage ratio of -221.6x, meaning it can struggle to cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

BCHTD (BCHTD) scores 32 out of 100 on our Financial Profile, indicating weak overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.

Back to top